Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2132 of 6351
-
Could a single nerve block slash opioid use in Children's elbow surgery?
Symptom relief CompletedWe hypothesize that patients who receive a supraclavicular block via Angiocath, placed intra-operatively and dosed post-operatively following neurologic examination, will have lower pain scores, lower use of intravenous morphine equivalents in the post-anesthesia care unit, and l…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New radiation regimen aims to cut prostate cancer treatment time
Disease control CompletedThis will be a Phase II study evaluating the effectiveness and toxicity of a specific radiation therapy regimen. This choice of daily dose is based on the prior published experience showing safety and efficacy of hypofractionated regimens. The total dose is calculated to be effec…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Cheap arthritis drug could tame severe eczema
Disease control CompletedThe systemic treatments for moderate to severe atopic dermatitis (AD) are limited to phototherapy and cyclosporine with the risks respectively of either carcinoma, or hypertension or nephropathy. Methotrexate was effective in 75% of moderate to severe AD patients with good toler…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
One-Dose hope for blistering skin disease?
Disease control CompletedThe aim of the study is to assess that it will be possible to control with a single cycle of rituximab patient with bullous pemphigoid.
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Fish oil for pregnant moms may shield babies from asthma
Prevention OngoingThe aim of this study is to prevent asthma and allergies in childhood by supplementation with fish oil (n-3 fatty acids) to the mother during pregnancy. Paticipants are mother and children participating in the ABC-(Asthma Begins in Childhood)cohort. Mothers are recruited during p…
Phase 1 • Sponsor: Copenhagen Studies on Asthma in Childhood • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
Nerve graft registry tracks recovery in thousands of patients
Disease control OngoingThis study is a registry of general use of Avance Nerve Graft and is intended to evaluate the uses, response rates, and safety of Avance Nerve Graft in the real-life clinical setting. Optional addendums 1 and 2 included in the protocol are intended to establish comparative groups…
Sponsor: Axogen Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Extra radiation boost may cut recurrence risk in early breast cancer
Disease control OngoingRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy after surgery may kill any tumor cells that remain after surgery. It is not yet known whether whole-breast radiation therapy is more effective when given with or without additional …
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New Cell-Based flu shot shows promise for older adults
Vaccine CompletedThe purpose of this study is to demonstrate the effectiveness (seroprotection and seroconversion as measured by the hemagglutination inhibition \[HI\] assay) of an investigational Vero cell-derived, trivalent, seasonal influenza vaccine in adults 50 years of age and older. Subjec…
Phase 3 • Sponsor: Alachua Government Services, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 08:08 UTC
-
New scan could reveal brain tumor aggression without surgery
Diagnosis CompletedThe primary objective of this study is to assess the efficacy of the radiopharmaceutical 3'-deoxy-3'-\[F-18\]fluorothymidine, \[F-18\]FLT, a tracor of cell proliferation, using Positron Emission Tomography (PET) imaging for the tumor diagnosis and prognosis in a group of 50 patie…
Sponsor: University Hospital, Caen • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
Can a single drug save rejected kidneys? new trial investigates
Disease control CompletedAssessing the impact of J12 curative treatment with rituximab (375 mg / m² on J5) based on a composite "TREATMENT FAILURE"
Phase 3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Milk under the tongue: a new hope for kids with dairy allergy?
Disease control CompletedSublingual immunotherapy is developing in the treatment of aeroallergens allergy. The hypothesis is that such process may be applied to food allergy, more precisely to milk. A previous series of 8 patients indicates the likely effectiveness of this technique (Allergy, 2006).
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Pregnancy lessons may curb baby weight gain
Prevention CompletedMetabolic environment of the foetus during pregnancy in obese women is altered and the child exposed at an increased risk of obesity. Rapid infancy and childhood weight gain is associated with subsequent obesity. The purpose of the study is to test the efficacy of an educational…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Pump delivery of hormone may steady calcium levels in rare disorder
Disease control CompletedThis randomized crossover study will evaluate the safety, efficacy, and pharmacodynamics of synthetic human PTH 1-34 (PTH) delivered by an insulin pump (omnipod) compared with twice- daily subcutaneous injections. We predict pump delivery of PTH will simultaneously normalize bloo…
Phase 2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of veliparib, cyclophosphamide, and doxorubicin hydrochloride when given together in treating patients solid tumors or non-Hodgkin lymphoma that has spread to other areas of the body or cannot be removed by surgery. Velipa…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Modified virus injected into tumors shows promise for liver cancer
Disease control CompletedThe purpose of this research study is to determine whether JX-594 (Pexa-Vec) has significant anti-tumoral activity and tolerability in primary hepatocellular carcinoma and to determine the dose to be used in further testing.
Phase 2 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Once-a-Month shot could ease anemia for kidney patients
Disease control CompletedThis single arm study will assess the efficacy and safety of subcutaneous methoxy polyethylene glycol-epoetin beta (Mircera) for the correction and maintenance of hemoglobin levels in predialysis patients with renal anemia who are not currently treated with erythropoietin stimula…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 26, 2026 16:43 UTC
-
Can a Blood-Vessel drug shield weak hearts during surgery?
Disease control CompletedA robust release of endothelin-1-1 (ET) with subsequent ETA subtype receptor (ET-AR) activation occurs in patients following cardiac surgery requiring cardiopulmonary bypass (CPB). Increased ET-AR activation has been identified in patients with poor left ventricular (LV) function…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Chemo cocktail aims to shrink sinus tumors and save faces
Disease control Stopped earlyThis phase II trial studies how well docetaxel, cisplatin and fluorouracil work in treating patients with previously untreated stage II-IV nasal cavity and/or paranasal sinus cancer. Drugs used in chemotherapy, such as docetaxel, cisplatin and fluorouracil, work in different ways…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Osteoporosis drug may strengthen bones beyond density, new study hints
Disease control OngoingThis study will investigate the effects on bone quality of a medication (Teriparatide) used to treat people with severe osteoporosis. Teriparatide is the only bone formation therapy that has been approved for the treatment of postmenopausal osteoporosis in Canada. Osteoporosis is…
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Heart drug hopes to shield dialysis patients from deadly attacks
Disease control OngoingNicorandil is potentially effective to prevent cardiovascular events in patients with coronary artery disease (CAD) receiving hemodialysis. The purpose of this study is to prospectively investigate whether nicorandil is effective in reducing the incidence of cardiovascular events…
Phase 4 • Sponsor: Kumamoto University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC